Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Topotecan × Other hematologic neoplasm × Clear all

Phase

Status

Completed 22 Terminated 2 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 9 Gynecologic 8 Other solid neoplasm 4 CNS 4 Tumor-Agnostic 1 Sarcoma 1 Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

venetoclax 176 Cyclophosphamide 111 Azacitidine 105 Cytarabine 97 fludarabine 83 Specimen Handling 69 Biopsy 51 Daunorubicin 37 Methotrexate 36 Dexamethasone 34 Rituximab 33 fludarabine phosphate 31 Decitabine 28 blinatumomab 27 Vincristine 27 Injections 27 Granulocyte Colony-Stimulating Factor 26 Magnetic Resonance Spectroscopy 25 obinutuzumab 24 Idarubicin 23 Whole-Body Irradiation 22 acalabrutinib 21 Prednisone 20 Mycophenolic Acid 19 ibrutinib 18 Melphalan 18 Doxorubicin 18 Busulfan 18 Cladribine 17 ruxolitinib 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05101551 2025-05-29

PARPAML

Stanford University

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡